dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-5,7-dimethyl-1-[3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;2-methyl-5-[8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-yl]-1,3-thiazole;oxido formate

C56H64BBrK2N10O7S2 — CID 162202253

IUPACdipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-5,7-dimethyl-1-[3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;2-methyl-5-[8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-yl]-1,3-thiazole;oxido formate
SMILESC.CC1C(=O)N(C)Cc2c(Br)nc(C3CC3)n21.Cc1ncc(-c2cc3cccc(-c4nc(C5CC5)n5c4CN(C)C(=O)C5C)c3cn2)s1.Cc1ncc(-c2cc3cccc(B4OC(C)(C)C(C)(C)O4)c3cn2)s1.O=CO[O-].[H-].[K+].[K+]
InChIInChI=1S/C24H23N5OS.C19H21BN2O2S.C11H14BrN3O.CH2O3.CH4.2K.H/c1-13-24(30)28(3)12-20-22(27-23(29(13)20)15-7-8-15)17-6-4-5-16-9-19(26-10-18(16)17)21-11-25-14(2)31-21;1-12-21-11-17(25-12)16-9-13-7-6-8-15(14(13)10-22-16)20-23-18(2,3)19(4,5)24-20;1-6-11(16)14(2)5-8-9(12)13-10(15(6)8)7-3-4-7;2-1-4-3;;;;/h4-6,9-11,13,15H,7-8,12H2,1-3H3;6-11H,1-5H3;6-7H,3-5H2,1-2H3;1,3H;1H4;;;/q;;;;;2*+1;-1/p-1
InChIKeyYPNYEGJBIGOKLG-UHFFFAOYSA-M
MW1222.24 g/mol
LogP4.15
Rot. Bonds7

About dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-5,7-dimethyl-1-[3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;2-methyl-5-[8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-yl]-1,3-thiazole;oxido formate

dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-5,7-dimethyl-1-[3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;2-methyl-5-[8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-yl]-1,3-thiazole;oxido formate (PubChem CID 162202253) has the molecular formula C56H64BBrK2N10O7S2 and a molecular weight of 1222.24 g/mol. Its IUPAC name is dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-5,7-dimethyl-1-[3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;2-methyl-5-[8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-yl]-1,3-thiazole;oxido formate.

Molecular Properties

Compound Namedipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-5,7-dimethyl-1-[3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;2-methyl-5-[8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-yl]-1,3-thiazole;oxido formate
PubChem CID162202253
Molecular FormulaC56H64BBrK2N10O7S2
Molecular Weight1222.24 g/mol
Exact Mass1220.30
IUPAC Namedipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-5,7-dimethyl-1-[3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;2-methyl-5-[8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-yl]-1,3-thiazole;oxido formate
SMILESC.CC1C(=O)N(C)Cc2c(Br)nc(C3CC3)n21.Cc1ncc(-c2cc3cccc(-c4nc(C5CC5)n5c4CN(C)C(=O)C5C)c3cn2)s1.Cc1ncc(-c2cc3cccc(B4OC(C)(C)C(C)(C)O4)c3cn2)s1.O=CO[O-].[H-].[K+].[K+]
InChIInChI=1S/C24H23N5OS.C19H21BN2O2S.C11H14BrN3O.CH2O3.CH4.2K.H/c1-13-24(30)28(3)12-20-22(27-23(29(13)20)15-7-8-15)17-6-4-5-16-9-19(26-10-18(16)17)21-11-25-14(2)31-21;1-12-21-11-17(25-12)16-9-13-7-6-8-15(14(13)10-22-16)20-23-18(2,3)19(4,5)24-20;1-6-11(16)14(2)5-8-9(12)13-10(15(6)8)7-3-4-7;2-1-4-3;;;;/h4-6,9-11,13,15H,7-8,12H2,1-3H3;6-11H,1-5H3;6-7H,3-5H2,1-2H3;1,3H;1H4;;;/q;;;;;2*+1;-1/p-1
InChIKeyYPNYEGJBIGOKLG-UHFFFAOYSA-M
XLogP4.15
TPSA195.64 Ų
H-Bond Donors
H-Bond Acceptors17
Rotatable Bonds7
Heavy Atoms79
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001222.24
LogP ≤ 54.15
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'}

Analyze dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-5,7-dimethyl-1-[3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;2-methyl-5-[8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-yl]-1,3-thiazole;oxido formate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-5,7-dimethyl-1-[3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;2-methyl-5-[8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-yl]-1,3-thiazole;oxido formate?
The IUPAC name of dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-5,7-dimethyl-1-[3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;2-methyl-5-[8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-yl]-1,3-thiazole;oxido formate (CID 162202253) is dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-5,7-dimethyl-1-[3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;2-methyl-5-[8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-yl]-1,3-thiazole;oxido formate.
What is the SMILES notation for dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-5,7-dimethyl-1-[3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;2-methyl-5-[8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-yl]-1,3-thiazole;oxido formate?
The canonical SMILES for dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-5,7-dimethyl-1-[3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;2-methyl-5-[8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-yl]-1,3-thiazole;oxido formate is C.CC1C(=O)N(C)Cc2c(Br)nc(C3CC3)n21.Cc1ncc(-c2cc3cccc(-c4nc(C5CC5)n5c4CN(C)C(=O)C5C)c3cn2)s1.Cc1ncc(-c2cc3cccc(B4OC(C)(C)C(C)(C)O4)c3cn2)s1.O=CO[O-].[H-].[K+].[K+].
What is the InChIKey of dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-5,7-dimethyl-1-[3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;2-methyl-5-[8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-yl]-1,3-thiazole;oxido formate?
The InChIKey is YPNYEGJBIGOKLG-UHFFFAOYSA-M. The full InChI is InChI=1S/C24H23N5OS.C19H21BN2O2S.C11H14BrN3O.CH2O3.CH4.2K.H/c1-13-24(30)28(3)12-20-22(27-23(29(13)20)15-7-8-15)17-6-4-5-16-9-19(26-10-18(16)17)21-11-25-14(2)31-21;1-12-21-11-17(25-12)16-9-13-7-6-8-15(14(13)10-22-16)20-23-18(2,3)19(4,5)24-20;1-6-11(16)14(2)5-8-9(12)13-10(15(6)8)7-3-4-7;2-1-4-3;;;;/h4-6,9-11,13,15H,7-8,12H2,1-3H3;6-11H,1-5H3;6-7H,3-5H2,1-2H3;1,3H;1H4;;;/q;;;;;2*+1;-1/p-1.
What are the key properties of dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-5,7-dimethyl-1-[3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;2-methyl-5-[8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-yl]-1,3-thiazole;oxido formate?
dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-5,7-dimethyl-1-[3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;2-methyl-5-[8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-yl]-1,3-thiazole;oxido formate has a molecular weight of 1222.24 g/mol, XLogP of 4.15, 7 rotatable bonds, 0 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-5,7-dimethyl-1-[3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;2-methyl-5-[8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-yl]-1,3-thiazole;oxido formate is sourced from PubChem (CID 162202253), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).